AstraZeneca confident rare-disease drug can hit target after mixed study results

  • Posted on March 31, 2026
  • By Bing News
  • 3 Views
AstraZeneca confident rare-disease drug can hit target after mixed study results
AstraZeneca confident rare-disease drug can hit target after mixed study results

The company said the results support the drug’s potential to transform the treatment of hypophosphatasia and it plans to submit data to regulators as soon as possible.
continue reading...

Author
No Image
Bing News

You May Also Like